Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Ramage%2C+Cassandra+L%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Ramage%2C+Cassandra+L%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Ramage%2C+Cassandra+L%22&type=Person&sort=year
PubPharm (7)
1
Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML
enthalten in:
bioRxiv.org
| 2024
von
Mohanty, V.
|
Baran, N.
|
Huang, Y.
| +9
Wird geladen...
2
Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML
enthalten in:
bioRxiv : the preprint server for biology
| 2024
von
Mohanty, V.
|
Baran, N.
|
Huang, Y.
| +10
Wird geladen...
3
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro
enthalten in:
Biochemical pharmacology
| 2024
von
Hurrish, K.
|
Su, Y.
|
Patel, S.
| +26
UpdateOf: Res Sq. 2023 Apr 28;:. - PMID 37162954
Wird geladen...
4
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells
enthalten in:
Haematologica
| 2023
von
Jia, Y.
|
Han, L.
|
Ramage, C.
| +17
Wird geladen...
5
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis
enthalten in:
Research square
| 2023
von
Hurrish, K.
|
Su, Y.
|
Patel, S.
| +24
UpdateIn: Biochem Pharmacol. 2023 Dec 10;220:115981. - PMID 38081370
Wird geladen...
6
Correction : Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
enthalten in:
Signal transduction and targeted therapy
| 2022
von
Zhang, Q.
|
Riley-Gillis, B.
|
Han, L.
| +38
ErratumFor: Signal Transduct Target Ther. 2022 Feb 21;7(1):51. - PMID 35185150
Wird geladen...
7
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
enthalten in:
Signal transduction and targeted therapy
| 2022
von
Zhang, Q.
|
Riley-Gillis, B.
|
Han, L.
| +38
ErratumIn: Signal Transduct Target Ther. 2022 Apr 1;7(1):110. - PMID 35365596
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
7
Aufsätze
7
E-Artikel
7
E-Ressourcen
Zeitschriftentitel
2
Signal transduction and targeted therapy
1
Biochemical pharmacology
1
Haematologica
1
Research square
1
bioRxiv : the preprint server for biology
1
bioRxiv.org
Alle anzeigen ...
weniger ...
Thema
3
Journal Article
3
venetoclax
2
Acute myeloid leukemia
2
Bridged Bicyclo Compounds, Heterocyclic
2
ME-344
2
N54AIC43PW
2
Preprint
2
Proto-Oncogene Proteins c-bcl-2
2
Research Support, N.I.H., Extramural
2
Research Support, Non-U.S. Gov't
2
Sulfonamides
1
570
1
843G0TDV51
1
Antineoplastic Agents
1
BCL2 protein, human
1
Biology
1
EC 3.6.5.2
1
Isoflavones
1
MCL1 protein, human
1
Myeloid Cell Leukemia Sequence 1 Protein
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2024
2
2023
2
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7
Englisch
Haven't found what you're looking for?
Wird geladen...